Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
Dragana Bugarski-Kirola, Celso Arango, Maurizio Fava, Henry Nasrallah, I-Yuan Liu, Brandon Abbs, Srdjan Stankovic
Topics & Concepts
MedicineMEDLINEPhase (matter)Environmental healthClinical trial2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Environmental protectionYoung adultSchizophrenia research and treatmentPsychedelics and Drug StudiesSleep and Wakefulness Research